Granules India Limited (NSE:GRANULES)
583.10
-16.25 (-2.71%)
At close: Jan 16, 2026
Granules India Employees
Granules India had 4,066 employees as of March 31, 2025. The number of employees increased by 9 or 0.22% compared to the previous year.
Employees
4,066
Change (1Y)
9
Growth (1Y)
0.22%
Revenue / Employee
11.91M INR
Profits / Employee
1.26M INR
Market Cap
141.14B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4,066 | 9 | 0.22% |
| Mar 31, 2024 | 4,057 | 407 | 11.15% |
| Mar 31, 2023 | 3,650 | -36 | -0.98% |
| Mar 31, 2022 | 3,686 | 317 | 9.41% |
| Mar 31, 2021 | 3,369 | 340 | 11.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Biocon | 16,315 |
Granules India News
- 10 days ago - Granules India subsidiary gets FDA tentative approval for generic DYANAVEL XR tablets - Business Upturn
- 26 days ago - Granules India board approves fundraise of upto Rs 1,462 crore via issue of warrants at Rs 585 - Business Upturn
- 27 days ago - Granules India subsidiary receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets - Business Upturn
- 4 weeks ago - Granules India subsidiary completes USFDA inspection with five procedural observations - Business Upturn
- 4 weeks ago - Granules India subsidiary receives five procedural observations after US FDA GMP inspection - Business Upturn
- 5 weeks ago - Granules India subsidiary secures FDA EIR for Hyderabad Facility - Business Upturn
- 6 weeks ago - Granules packaging unit clears USFDA inspection - The Times of India
- 6 weeks ago - Granules India’s US Packaging Facility Clears FDA Inspection With Zero Observations - Business Upturn